BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Early FDA wins: Corcept’s Lifyorli, Denali’s Avlayah
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Cancer
BioWorld Science, Cancer
RSS
Pfizer team presents novel GnRH antagonists in a recent patent
Feb. 3, 2004
Merck presents novel KSP inhibitors with utility in cancer therapy
Feb. 3, 2004
Cerus acquires mesothelin rights from Johns Hopkins University
Feb. 2, 2004
New phase I trial for RSR-13 in locally advanced NSCLC
Feb. 2, 2004
Bevacizumab inhibits tumor vascularity
Feb. 2, 2004
Exelixis scientists present new antiangiogenic ADAM-10 inhibitors
Feb. 2, 2004
Antitumor effects reported for erlotinib in metastatic head and neck cancer
Feb. 2, 2004
Xcytrin enters phase I trial in combination with Temodar for glioma
Jan. 30, 2004
Provectus prepares IND filing for Provecta
Jan. 30, 2004
Phase III Thymitaq trial cleared to continue by DSMB
Jan. 30, 2004
Previous
1
2
…
2923
2924
2925
2926
2927
2928
2929
2930
2931
…
3671
3672
Next
RSS